Bausch + Lomb Corporation (FRA:S2L)

Market Cap	5.57B +16.4%
Revenue (ttm)	4.66B +8.9%
Net Income	-149.68M
EPS	-0.43
Shares Out	n/a
PE Ratio	n/a
Forward PE	16.86
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	15.30
Previous Close	15.00
Day's Range	15.20 - 15.30
52-Week Range	12.50 - 15.70
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About Bausch + Lomb

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during heali...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1853
• Employees: 13,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: S2L

Financial Performance

In 2025, Bausch + Lomb's revenue was $5.10 billion, an increase of 6.47% compared to the previous year's $4.79 billion. Losses were -$360.00 million, 13.6% more than in 2024.

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 25, 2026

Data Sources Report a data error